Lilly Ultra Long acting Insulin Phase III Clinical Success
六月清晨搅
发表于 2024-5-16 20:55:31
244
0
0
[Phase III clinical success of Eli Lilly ultra long-acting insulin] Eli Lilly announced that the weekly injection of ultra long-acting insulin Insulin Efstora Alfa in the treatment of type II diabetes, two phase III clinical QWINT-2 and QWINT-4, obtained positive data.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- European regulators recommend approval of insulin once a week for treatment of diabetes
- Novo Nordisk Ultra Long acting Insulin Global First Batch Expected Within Two Months
- Before the United States! What is the safety and efficacy of the world's first weekly insulin injection approved in China
- The world's first weekly insulin preparation has encountered setbacks in the United States, and the FDA requires additional information, with no hope of approval this year
- Novo Nordisk reportedly faces US congressional review for halting sales of long-acting insulin Levemir in the US
- Novo Nordisk's world's first weekly insulin preparation, Novo Nordisk, has been included in the national medical insurance catalog